Literature DB >> 35132162

Artificial intelligence-assisted mapping of proliferation centers allows the distinction of accelerated phase from large cell transformation in chronic lymphocytic leukemia.

Siba El Hussein1,2, Pingjun Chen3, L Jeffrey Medeiros2, John D Hazle3, Jia Wu4, Joseph D Khoury5.   

Abstract

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) is characterized morphologically by numerous small lymphocytes and pale nodules composed of prolymphocytes and paraimmunoblasts known as proliferation centers (PCs). Patients with CLL can undergo transformation to a more aggressive lymphoma, most often diffuse large B-cell lymphoma (DLBCL), known as Richter transformation (RT). An accelerated phase of CLL (aCLL) also may be observed which correlates with subsequent transformation to DLBCL, and may represent an early stage of transformation. Distinguishing PCs in CLL from aCLL or RT can be diagnostically challenging, particularly in small needle biopsy specimens. Available guidelines pertaining to distinguishing CLL from its' progressive forms are limited, subject to the morphologist's experience and are often not completely helpful in the assessment of scant biopsy specimens. To objectively assess the extent of PCs in aCLL and RT, and enhance diagnostic accuracy, we sought to design an artificial intelligence (AI)-based tool to identify and delineate PCs based on feature analysis of the combined individual nuclear size and intensity, designated here as the heat value. Using the mean heat value from the generated heat value image of all cases, we were able to reliably separate CLL, aCLL and RT with sensitive diagnostic predictive values.
© 2022. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology.

Entities:  

Mesh:

Year:  2022        PMID: 35132162      PMCID: PMC9329234          DOI: 10.1038/s41379-022-01015-9

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   8.209


  13 in total

1.  Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays.

Authors:  M Ciccone; C Agostinelli; G M Rigolin; P P Piccaluga; F Cavazzini; S Righi; M T Sista; O Sofritti; L Rizzotto; E Sabattini; G Fioritoni; S Falorio; C Stelitano; A Olivieri; I Attolico; M Brugiatelli; P L Zinzani; E Saccenti; D Capello; M Negrini; A Cuneo; S Pileri
Journal:  Leukemia       Date:  2011-09-23       Impact factor: 11.528

2.  Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior.

Authors:  Eva Giné; Antoni Martinez; Neus Villamor; Armando López-Guillermo; Mireia Camos; Daniel Martinez; Jordi Esteve; Xavier Calvo; Ana Muntañola; Pau Abrisqueta; Maria Rozman; Ciril Rozman; Francesc Bosch; Elias Campo; Emili Montserrat
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

3.  How we treat Richter syndrome.

Authors:  Sameer A Parikh; Neil E Kay; Tait D Shanafelt
Journal:  Blood       Date:  2014-01-13       Impact factor: 22.113

4.  Hover-Net: Simultaneous segmentation and classification of nuclei in multi-tissue histology images.

Authors:  Simon Graham; Quoc Dang Vu; Shan E Ahmed Raza; Ayesha Azam; Yee Wah Tsang; Jin Tae Kwak; Nasir Rajpoot
Journal:  Med Image Anal       Date:  2019-09-18       Impact factor: 8.545

5.  Automated Diagnosis of Lymphoma with Digital Pathology Images Using Deep Learning.

Authors:  Hanadi El Achi; Tatiana Belousova; Lei Chen; Amer Wahed; Iris Wang; Zhihong Hu; Zeyad Kanaan; Adan Rios; Andy N D Nguyen
Journal:  Ann Clin Lab Sci       Date:  2019-03       Impact factor: 1.256

6.  Deep learning shows the capability of high-level computer-aided diagnosis in malignant lymphoma.

Authors:  Hiroaki Miyoshi; Kensaku Sato; Yoshinori Kabeya; Sho Yonezawa; Hiroki Nakano; Yusuke Takeuchi; Issei Ozawa; Shoichi Higo; Eriko Yanagida; Kyohei Yamada; Kei Kohno; Takuya Furuta; Hiroko Muta; Mai Takeuchi; Yuya Sasaki; Takuro Yoshimura; Kotaro Matsuda; Reiji Muto; Mayuko Moritsubo; Kanako Inoue; Takaharu Suzuki; Hiroaki Sekinaga; Koichi Ohshima
Journal:  Lab Invest       Date:  2020-05-29       Impact factor: 5.662

7.  Improving Augmented Human Intelligence to Distinguish Burkitt Lymphoma From Diffuse Large B-Cell Lymphoma Cases.

Authors:  Jeffrey S Mohlman; Samuel D Leventhal; Taft Hansen; Jessica Kohan; Valerio Pascucci; Mohamed E Salama
Journal:  Am J Clin Pathol       Date:  2020-05-05       Impact factor: 2.493

8.  Histopathologic and Machine Deep Learning Criteria to Predict Lymphoma Transformation in Bone Marrow Biopsies.

Authors:  Lina Irshaid; Jonathan Bleiberg; Ethan Weinberger; James Garritano; Rory M Shallis; Jonathan Patsenker; Ofir Lindenbaum; Yuval Kluger; Samuel G Katz; Mina L Xu
Journal:  Arch Pathol Lab Med       Date:  2022-01-02       Impact factor: 5.534

9.  Accurate diagnosis of lymphoma on whole-slide histopathology images using deep learning.

Authors:  Charlotte Syrykh; Arnaud Abreu; Nadia Amara; Aurore Siegfried; Véronique Maisongrosse; François X Frenois; Laurent Martin; Cédric Rossi; Camille Laurent; Pierre Brousset
Journal:  NPJ Digit Med       Date:  2020-05-01

10.  A deep learning diagnostic platform for diffuse large B-cell lymphoma with high accuracy across multiple hospitals.

Authors:  Dongguang Li; Jacob R Bledsoe; Yu Zeng; Wei Liu; Yiguo Hu; Ke Bi; Aibin Liang; Shaoguang Li
Journal:  Nat Commun       Date:  2020-11-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.